Journals / Sakarya Tıp Dergisi / 2020 / Cilt: 10 - Sayı: 4

Evaluation of Intra-hospital and Long-term Mortality in Patients Presenting with ST-segment Elevation Myocardial Infarction: A Tertiary Cardiology Center Experience

ST Segment Yükselmeli Miyokard İnfarktüsü ile Başvuran Hastalarda Hastane İçi ve Uzun Dönem Mortalitenin Değerlendirilmesi: Üçüncü Basamak Kardiyoloji Merkezi Deneyimi

Pages
600–607
Publication Date
2020-12-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These patients were divided into three groups according to age (Group-1:

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Ischemic heart disease remains the leading cause of death.
📊
Key Findings & Data:Not only strategies of health care providers but also population characteristics are also important to extend life expectancy in patients with cardiovascular disease.
💡
Conclusion & Impact:These patients were divided into three groups according to age (Group-1:
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:ST elevasyonlu miyokart enfarktüsü · uzun sureli sonuçlar · mortalite

Abstract

Objective: Ischemic heart disease remains the leading cause of death. Not only strategies of health care providers but also population characteristics are also important to extend life expectancy in patients with cardiovascular disease. Thus clinical studies including national cohort of patients provide important insights into the real-life health care. We aimed to assess intra-hospital and long-term outcomes in patients with ST-elevation myocardial infarction (STEMI). Materials and Methods: A total of 178 STEMI patients treated with primary percutaneous coronary intervention (PCI), who were documented to be death or responded the telephone interview, were included into the analyses. These patients were divided into three groups according to age (Group-1:

Özet

Amaç: İskemik kalp hastalığı tüm dünyada önde gelen bir ölüm sebebidir ve kardiyovasküler hastalığı olan hastalarda yaşam beklentisini uzatmak için sadece sağlık hizmeti sağlayıcılarının stratejileri değil, toplum özellikleri de önem arz etmektedir. Bu nedenle, ilgilenilen toplum özelliklerini yansıtan, ulusal, klinik çalışmalar gerçek yaşam sağlık hizmetleri hakkında önemli bilgiler vermektedir. Biz bu çalışma ile üçüncü basamak kardiyoloji merkezimize başvuran ST elevasyonlu miyokart enfarktüsü (STEMI) hastalarında hastane içi ve uzun dönem sonuçlarımızı değerlendirmeyi amaçladık. Gereç ve Yöntemler: Primer perkütan koroner girişim (PCI) ile tedavi edilen ve telefon ile yaptığımız sorgulamalara cevap veren veya takiplerinde vefat ettiği belgelenen toplam 178 STEMI hastası analizlere dâhil edildi. Bu hastalar yaşa göre üç gruba ayrıldı (Grup-1:

🔖

Cite This Article

SAVAŞ, G., KIZILAY, M., SÜZER, M. (2020). Evaluation of Intra-hospital and Long-term Mortality in Patients Presenting with ST-segment Elevation Myocardial Infarction: A Tertiary Cardiology Center Experience. Sakarya Tıp Dergisi, Cilt: 10 - Sayı: 4, 600–607. https://ajindex.com/articles/261341

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Szummer K, Wallentin L, Lindhagen L, Alfredsson J, Erlinge D, Held C, et al.Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014. Eur Heart J 2017;38:3056-3065
  2. World Health Organization, Top 10 causes of death.
  3. Fervers B, Burgers JS, Haugh MC, Latreille J, Mlika-Cabanne N, Paquet L, et al. Adaptation of clinical guidelines: literature review and proposition for a framework and procedure. Int J Qual Health Care 2006;18:167-76
  4. Ui S, Chino M, Isshiki T. Rates of primary percutaneous coronary intervention worldwide. Circ J 2005;69:95-100
  5. The Lancet. 40 years of percutaneous coronary intervention: where next? Lancet 2017;390:715
  6. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH), European Heart Journal 2018; 39,3021–3104
  7. Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD), European Heart Journal 2020; 41,255–323
  8. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-100
  9. Schuijf JD, Wijns W, Jukema JW, Atsma DE, de Roos A, Lamb HJ, Stokkel MP, et al. Relationship between noninvasive coronary angiography with multi-slice computed tomography and myocardial perfusion imaging. J Am Coll Cardiol 2006; 48:2508-14
  10. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18, 499-502
  11. Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J 2016;37: 3232–3245. 1